Cargando…

Evaluation of the adverse events following immunization surveillance system, Ghana, 2019

BACKGROUND: With over 80% of children worldwide vaccinated, concerns about vaccine safety continues to be a public health issue. Ghana’s Adverse Events Following Immunization surveillance started in 1978 with the objective to promptly detect and manage AEFI cases either real or perceived. Periodic e...

Descripción completa

Detalles Bibliográficos
Autores principales: Laryea, Eunice Baiden, Frimpong, Joseph Asamoah, Noora, Charles Lwanga, Tengey, John, Bandoh, Delia, Sabblah, George, Ameme, Donne, Kenu, Ernest, Amponsa-Achiano, Kwame
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887767/
https://www.ncbi.nlm.nih.gov/pubmed/35231049
http://dx.doi.org/10.1371/journal.pone.0264697
_version_ 1784660978084872192
author Laryea, Eunice Baiden
Frimpong, Joseph Asamoah
Noora, Charles Lwanga
Tengey, John
Bandoh, Delia
Sabblah, George
Ameme, Donne
Kenu, Ernest
Amponsa-Achiano, Kwame
author_facet Laryea, Eunice Baiden
Frimpong, Joseph Asamoah
Noora, Charles Lwanga
Tengey, John
Bandoh, Delia
Sabblah, George
Ameme, Donne
Kenu, Ernest
Amponsa-Achiano, Kwame
author_sort Laryea, Eunice Baiden
collection PubMed
description BACKGROUND: With over 80% of children worldwide vaccinated, concerns about vaccine safety continues to be a public health issue. Ghana’s Adverse Events Following Immunization surveillance started in 1978 with the objective to promptly detect and manage AEFI cases either real or perceived. Periodic evaluation of the surveillance system is critical for optimal performance; hence we evaluated the system to assess its attributes, usefulness and system’s performance in meeting its objectives. METHODS: A case of AEFI was defined as any untoward medical event occurring within 28 days after vaccination and may not necessarily have causal relationship with the vaccine use. We reviewed surveillance data and procedures for the period 2014 to 2018 and interviewed key stakeholders. Adapting the CDC’s Updated Guidelines for Evaluating Public Health Surveillance Systems, we assessed the system’s attributes and usefulness. We performed summary descriptive statistics on quantitative data and directed content analysis on information gathered from interviews. RESULTS: In all, 2,282 AEFI cases including 476 (21%) serious cases (life threatening events) were reported for the period. The highest case detection rates of 61.45 AEFIs per 100,000 surviving infants was recorded in 2018. Reporting forms were modified to accommodate new indicators without any disruption in the function of the system. At the national level, completeness of 100 randomly sampled reporting forms (100%) and was higher than the region (27%) but timeliness (50%) was lower than the region (83%). All (16/16) Community Health Nurses interviewed indicated “fear of being victimized” as the reason for underreporting, nonetheless, the system was useful as it made them cautious when vaccinating children to prevent reactions. Data on AEFI surveillance was also useful in guiding training needs and provision of vaccination logistics. CONCLUSION: The AEFI surveillance system is useful at all levels but partially meeting its objective due to underreporting. We recommend training and supportive supervision to improve timeliness of reporting, data completeness and acceptability.
format Online
Article
Text
id pubmed-8887767
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-88877672022-03-02 Evaluation of the adverse events following immunization surveillance system, Ghana, 2019 Laryea, Eunice Baiden Frimpong, Joseph Asamoah Noora, Charles Lwanga Tengey, John Bandoh, Delia Sabblah, George Ameme, Donne Kenu, Ernest Amponsa-Achiano, Kwame PLoS One Research Article BACKGROUND: With over 80% of children worldwide vaccinated, concerns about vaccine safety continues to be a public health issue. Ghana’s Adverse Events Following Immunization surveillance started in 1978 with the objective to promptly detect and manage AEFI cases either real or perceived. Periodic evaluation of the surveillance system is critical for optimal performance; hence we evaluated the system to assess its attributes, usefulness and system’s performance in meeting its objectives. METHODS: A case of AEFI was defined as any untoward medical event occurring within 28 days after vaccination and may not necessarily have causal relationship with the vaccine use. We reviewed surveillance data and procedures for the period 2014 to 2018 and interviewed key stakeholders. Adapting the CDC’s Updated Guidelines for Evaluating Public Health Surveillance Systems, we assessed the system’s attributes and usefulness. We performed summary descriptive statistics on quantitative data and directed content analysis on information gathered from interviews. RESULTS: In all, 2,282 AEFI cases including 476 (21%) serious cases (life threatening events) were reported for the period. The highest case detection rates of 61.45 AEFIs per 100,000 surviving infants was recorded in 2018. Reporting forms were modified to accommodate new indicators without any disruption in the function of the system. At the national level, completeness of 100 randomly sampled reporting forms (100%) and was higher than the region (27%) but timeliness (50%) was lower than the region (83%). All (16/16) Community Health Nurses interviewed indicated “fear of being victimized” as the reason for underreporting, nonetheless, the system was useful as it made them cautious when vaccinating children to prevent reactions. Data on AEFI surveillance was also useful in guiding training needs and provision of vaccination logistics. CONCLUSION: The AEFI surveillance system is useful at all levels but partially meeting its objective due to underreporting. We recommend training and supportive supervision to improve timeliness of reporting, data completeness and acceptability. Public Library of Science 2022-03-01 /pmc/articles/PMC8887767/ /pubmed/35231049 http://dx.doi.org/10.1371/journal.pone.0264697 Text en © 2022 Laryea et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Laryea, Eunice Baiden
Frimpong, Joseph Asamoah
Noora, Charles Lwanga
Tengey, John
Bandoh, Delia
Sabblah, George
Ameme, Donne
Kenu, Ernest
Amponsa-Achiano, Kwame
Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title_full Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title_fullStr Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title_full_unstemmed Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title_short Evaluation of the adverse events following immunization surveillance system, Ghana, 2019
title_sort evaluation of the adverse events following immunization surveillance system, ghana, 2019
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8887767/
https://www.ncbi.nlm.nih.gov/pubmed/35231049
http://dx.doi.org/10.1371/journal.pone.0264697
work_keys_str_mv AT laryeaeunicebaiden evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT frimpongjosephasamoah evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT nooracharleslwanga evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT tengeyjohn evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT bandohdelia evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT sabblahgeorge evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT amemedonne evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT kenuernest evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019
AT amponsaachianokwame evaluationoftheadverseeventsfollowingimmunizationsurveillancesystemghana2019